Thank you for your interest in the AMP 2021 Annual Meeting & Expo!

The AMP 2021 Program Committee has been working hard to plan a comprehensive program, which we hope will encourage dialogue and foster discussion amongst attendees.


Preliminary Program:

Be sure to check back for updated Program information often!

Quick Links





Tuesday, November 16, 2021


8:30am - 3:45pm

AMP Reference Materials Forum

Satellite Events

Short Course

11:30am - 6:00pm

Board of Directors Meeting (Invitation Only)

4:00pm - 7:00pm

Attendee, Speaker, and Exhibitor Registration and Check-In


Board of Directors Dinner (Invitation Only)


Wednesday, November 17, 2021


7:00am - 5:00pm

Attendee, Speaker, and Exhibitor Registration and Check-In

7:30am - 3:00pm

GetAMPed! (Separate Registration)

8:00am - 7:00pm

Committee Meetings (Invitation Only)

8:00am - 5:00pm

Corporate Workshop Day (No Registration Required!)

1:30pm - 4:30pm

JMD Editorial Board Meeting (Invitation Only)

5:00pm - 6:00pm

Volunteer Appreciation Reception (Invitation Only)

7:00pm - 8:00pm

Trainee Networking Hour 


Thursday, November 18, 2021


6:30am - 8:00am

Poster Set-Up

7:00am - 5:00pm

Attendee, Speaker, and Exhibitor Registration and Check-In

7:00am - 8:00am

Continental Breakfast

11:30am - 7:15pm

Expo Hall Open

6:15pm - 7:15pm

Welcome Reception (In the Expo Hall)


7:15am - 8:45am

Independent Satellite Symposia

8:45am - 9:00am


9:00am - 10:30am


How to Weather the Next Pandemic: Lessons Learned from the COVID-19 EUA Process 

Panel Discussion

Jasmine Chaitram, MPH, MT (ASCP), CDC Division of Laboratory Systems, Atlanta, GA, USA

Karen L. Kaul, MD, PhD, NorthShore University Health System, Evanston, IL, USA

Timothy Stenzel, MD, PhD, US Food and Drug Administration, Rockville, MD, USA

New Insights into Cancer Biology from DNA Mutational Signatures

The Repertoire of Mutational Signatures in Human Cancer

Ludmil B. Alexandrov, PhD, University of California San Diego, La Jolla, CA, USA

Ongoing efforts to identify causes of currently unexplained signatures

Serena Nik-Zainal, MD, PhD, University of Cambridge, Cambridge, United Kingdom

10:30am - 10:45am


10:45am - 11:30am

AMP Working Group Meetings

11:30am - 11:45am


11:45am - 12:00pm

Opening Remarks

12:00pm - 1:00pm

AMP Award for Excellence in Molecular Diagnostics: Presentation and Lecture

CRISPRology: Science and Ethics of Genome Editing

Jennifer Doudna, PhD, University of California, Berkeley, CA, USA

1:00pm - 2:15pm

General Lunch - Visit Expo Hall and View Posters

Networking Lunches (Schedule)

Innovation Spotlight Stage (Schedule)

2:15pm - 3:30pm


Low Coverage Whole Genome Sequencing

Low-pass Genome Sequencing and Polygenic Risk Scores

Joe Pickrell, Gencove, New York, NY, USA

Low Coverage Whole Genome Sequencing

Julian Homburger, PhD, Color Health, Alamo, CA, USA

Alternative Perspectives to Multi-omics Single-cell Analysis

Alternative Perspectives to Multi-omics Single-cell Analysis

Robert B. Faryabi, PhD, MSc, University of Pennsylvania School of Medicine, Philadelphia, PA, USA

The Changing Landscape of Reimbursement for Pathology Clinical Consultation and Impact on Interpretation of Tumor Genomics

Current landscape of coding and reimbursement for tumor genomics interpretation and clinical correlation and consultation

Samuel K. Caughron, MD, MAWD Pathology Group, Lenexa, KS, USA

Tracking the Global Spread of Mutli-Drug Resistant Organisms

The Genomics, Evolution, and Spread of Drug-resistant Neisseria gonorrhoeae

Yonatan Grad, MD, PhD, Harvard Chan School of Public Health, Boston, MA, USA

Tracking the Global Spread of Mutli-Drug Resistant Organisms

Paul J. Planet, MD, PhD, University of Pennsylvania and Children's Hospital of Philadelphia, Philadelphia, PA, USA

New Developments in Mitochondrial DNA Variant Identification and Classification 

Mitochondrial DNA Variant Classification and MITOMAP

Marni J. Falk, MD, Children's Hospital of Philadelphia and University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA

3:30pm - 5:15pm

Coffee Break - Visit Expo Hall and View Posters

Innovation Spotlight Stage (Schedule)

5:15pm - 6:15pm


MRD for Lymphoma Beyond Immunoglobulin

Ash Alizadeh, MD, PhD, Color Health, Stanford, CA, USA

6:15pm - 7:15pm

Welcome Reception (In the Expo Hall)


Friday, November 19, 2021


7:00am - 5:00pm

Attendee, Speaker, and Exhibitor Registration and Check-In

7:00am - 8:00am

Continental Breakfast

9:00am - 4:00pm

Expo Hall Open


7:30am - 8:30am


Case Studies

Perspectives on Tumor Mutational Burden: An Update from the AMP TMB Working Group

Larissa V. Furtado, MD, St. Jude Children’s Research Hospital, Memphis, TN, USA

Lauren Ritterhouse, MD, PhD, Massachusetts General Hospital, Andover, MA, USA

Utilization of NGS Testing in Cytopathology Samples

Hamza N. Gokozan, MD, Weill Cornell Medicine, New York, NY, USA

Mitochondrial DNA as Clonal Markers to Infer and Track Clonal Mosaicism 

Vijay G. Sankaran, MD, PhD, Boston Children's Hospital/ Harvard Medical School, Boston, MA, USA

8:30am - 8:45am


8:45am - 9:45am


How Far are We from an HIV Cure?  Implications for Molecular Diagnostics 

Pathways Towards an HIV Cure? Implications for Molecular Diagnostics

Deborah Persaud, MD, Johns Hopkins University School of Medicine, Baltimore, MD, USA

9:45am - 10:45am

Coffee Break - Visit Expo Hall and View Posters

(Even-numbered posters Attended)

Innovation Spotlight Stage (Schedule)

10:45am - 12:15pm


Negotiating in a Hostage Situation: Tips to Keep Your Lab Financially Solvent During COVID-19 and the Next Pandemic

Matt Charles, MPH, Northshore University HealthSystem, Chicago, IL, USA

Donna Wolk, Geisinger, Danville, PA , USA

Promises & Pitfalls of EHR-based Variant Reanalysis 

Variant Reclassification and Reinterpretation - Challenges and Opportunities in Current and Future EHR Usability and Function

Alexis Carter, MD, Children’s Healthcare of Atlanta, Atlanta, GA, USA

Improvement and Challenges of EHR System and Integration of Genomic Data

Alexis Carter, MD, Children’s Healthcare of Atlanta, Atlanta, GA, USA

Considerations for the Optimal Detection of Clinically Relevant Fusions in Solid Tumors 

Overview of the Various Methodologies for Fusion Detection in a Clinical Laboratory

John Iafrate, MD, PhD, Massachusetts General Hospital, Boston, MA, USA

Clinical Fusion Detection Approaches and Methodologies

Susan Hsiao, MD, PhD, Columbia University Medical Center, New York, NY, USA

Use of in Silico Data for Pipeline Development/Validation 

Sabah Kadri, Lurie Children's Hospital of Chicago, Chicago, IL, USA

Genetic Healthcare Disparities

Social Implications of Genetic Diagnosis and Therapies

John Carpten, PhD, University of Southern California, Los Angeles, CA, USA

Enabling Precision Medicine for Diverse Populations

Lucia Hindorff

Lack of Diversity in Genomics and Implications for Clinical Genetics

Alice B. Popejoy, PhD, University of California, Davis, Sacramento, CA, USA

12:15pm - 1:30pm

General Lunch - Visit Expo Hall and View Posters

Networking Lunches (Schedule)

Innovation Spotlight Stage (Schedule)

1:30pm - 3:00pm


Perspectives on the Applications of SARS CoV-2 Genome Sequencing

Panel Discussion

Jennifer Dien Bard, PHD, Children's Hospital of Los Angeles;  Keck School of Medicine, USC, South Pasadena, CA, USA

Kirsten St. George, M.App.Sc., PHD, Department of Health, Wadsworth Center, Albany, NY, USA

Pavitra Roychoudhury

Applications of Therapeutic Gene Editing 

Development and Application of Genome Editing Technologies

Fyodor Urnov, PhD, University of California, Berkeley, CA, USA

Gene Editing for the Treatment of Red Blood Cell Disorders

Haydar Frangoul, MD, Sarah Cannon Center for Blood Cancer, Nashville, TN, USA

3:00pm - 4:00pm

Coffee Break - Visit Expo Hall and View Posters

Innovation Spotlight Stage (Schedule)

4:00pm - 5:00pm


At the Intersection of Precision Medicine and Machine Learning 

Eliezer Van Allen, MD, Dana Farber Cancer Institute, Brookline, MA, USA

5:00pm - 5:15pm


5:15pm - 6:15pm

Business Meeting and Awards Session

(Open to All Registered Attendees)

7:00pm - 10:30pm

Social Event

(Separate Registration)



Saturday, November 20, 2021


7:00am - 2:00pm

Attendee, Speaker, and Exhibitor Registration and Check-In

7:00am - 8:00am

Continental Breakfast

9:00am - 1:30pm

Expo Hall Open

12:30pm - 1:30pm

Poster Removal


7:30am - 8:30am


Case Studies

Platform Presentations of Selected Technical Topics Abstracts

TT34 - Qualitative Detection of EGFR mutations (exons 18–21) in Lung cancer using Idylla Platform

Meenakshi Mehrotra, Icahn School of Medicine at Mount Sinai

TT25 - Urine-Based Testing for Mitochondrial Diseases: An Alternative to Invasive Muscle Biopsies?

Taylor Ashworth, Mayo Clinic

TT12 - Validation of Targeted Next-Generation Sequencing of Cell-Free DNA from Stored Cerebrospinal Fluid Specimens for the Detection of Somatic Variants in Cancer Involving the Leptomeninges

Alexander Neil, Brigham and Women's Hopsital

Difficult to Sequence Regions in the Genome 

Description of Hard to Sequence Regions

Justin M. Zook, PhD, NIST, Gaithersburg, MD, USA

Informatics Solutions to Difficult to Sequence Regions

Karen Miga

Advanced Sequencing Applications in the Public Health Laboratory

Molecular Streptococcus Pneumoniae Serotyping

Sara Vetter, PhD, D(ABMM), Minnesota State Public Health Laboratory, St. Paul, MN, USA

How NGS Is Used for Outbreak Detection

Heather Carleton, CDC, Atlanta, GA, USA

8:30am - 8:45am


8:45am - 9:45am


Advances in Clinical Applications for Complex Genetic Disorders 

9:45am - 10:45am

Coffee Break - Visit Expo Hall and View Posters

(Odd-numbered posters Attended)

Innovation Spotlight Stage (Schedule)

10:45am - 12:15pm


Molecular Diagnostics in the Community Hospital: How to Offer Complete and Up to Date Testing

Overview of Provision and Utilization of Molecular Testing in Community Cancer Centers, Ideally from an Individual Involved in the Association of Community Cancer Centers

Tabetha Sundin, PhD, HCLD (ABB), MB (ASCP)CM, AstraZeneca, Middletown, MD, USA

Experience from Molecular Pathologists Running Laboratories in a Community or Non-academic Setting, Discussing How They've Chosen What Types of Molecular Testing to Provide and How They Have Established Their Role in the Larger Molecular Laboratory Ecosystem

Michelle Shiller, DO, AP/CP, MGP, Baylor Scott & White Health, Dallas, TX, USA

Novel Insights into Clonal Hematopoiesis

Link Between Cancer Therapy and Clonal Hematopoiesis

Ahmet Zehir, PhD, Memorial Sloan Kettering Cancer Center, New York, NY, USA

Rationale for screening stem cell donors for clonal hematopoiesis

Lukasz Gondek

Rationale for not screening stem cell donors for clonal hematopoiesis

Coleman Lindsley, MD, PhD, Dana-Farber Cancer Institute, Boston, MA, USA

Pharmacogenomic Testing Across Populations 

Pharmacogenomics Implementation Across Populations in North America

Deepak Voora, MD, Duke University, Durham, NC, USA

Implementation of Pharmacogenetics in Clinical Care: an EU perspective

Ron HN Van Schaik, PhD, Erasmus MC, Rotterdam, Zuid-Holland, Netherlands

Pharmacogenomics in Pediatrics

Laura B. Ramsey, PhD, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA

Cool New Tech for At-Home Testing

Rapid, Point-of-Care Diagnostics

Catherine Klapperich, PhD, Boston University, Brookline, MA, USA

Cool New Tech for At-Home Testing

Jonathan Posner

Cool New Tech for At-Home Testing

Melanie Ott, MD, PhD, Gladstone Institute of Virology and UCSF, San Francisco, CA, USA

12:15pm - 1:30pm

General Lunch - Visit Expo Hall, and View Posters

Networking Lunches (Schedule)

Innovation Spotlight Stage (Schedule)

1:30pm - 2:30pm


Platform Presentations of Selected Abstracts

Abstracts are selected by the Program Committee

Platform Presentations of Selected Genetics Abstracts

G04 - A Comparison of Strategies for the Collection and Use of Phenotypic Information in the North Carolina Clinical Genomic Evaluation by Next-Generation Exome Sequencing 2 (NCGENES 2) Study

Shannon McNulty, University of NC, Chapel Hill

G28 - Implementing a Genomic Population Health Screening Program in Primary Care: Lessons Learned

Robert Wildin, University of Vermont Larner College of Medicine

G23 - COVID19 symptoms vary by HLA haplogroup in a well typed crowd cohort

Jeffrey Rosenfeld, Rutgers Cancer Institute of New Jersey

G01 - A Novel Machine Learning Plus Whole Methylome Approach for the Diagnosis of Germline Disorders

Linda Hasadsri, Mayo Clinic

Platform Presentations of Selected Hematopathology Abstracts

H27 - Comprehensive Genomic Profiling Discovers Recurrent Mutations and Copy Number Alterations of T-cell Large granular Lymphocytic Leukemia

Jinjuan Yao, Memorial Sloan Kettering Cancer Center

H19 - Clonal cytogenetic abnormalities in donor-derived cells after sex mismatched allogenic stem cell transplantation

Gokce Toruner, UT MD Anderson Cancer Center

H22 - Clinicopathologic Features of Acute Myeloid Leukemia with NUP98 Rearrangement

Maria Magallanes Hoyos, Oregon Health and Science University

H20 - AML with germline DDX41 mutations is a distinct clinicopathologically and molecularly defined entity with a sub-acute course and favorable outcome

Peng Li, University of Utah/ARUP Labs

Platform Presentations of Selected Infectious Diseases Abstracts

ID20 - Development and Six-Month Evaluation of SARS-CoV-2 Wastewater Surveillance in a Low-Prevalence Rural Region (The RECOVER Project)

Diana Toledo, Dartmouth-Hitchcock Medical Center

ID06 - Genetic variation in circulating SARS-CoV-2 is detected by RT-PCR/MALDI-TOF diagnostic targets

Matthew Hernandez, Icahn School of Medicine at Mount Sinai

ID24 - Fragment Analysis for Scalable Detection of SARS-CoV-2 Variants of Concern

Jeffrey SoRelle, UT Southwestern University

Platform Presentations of Selected Informatics Abstracts

I04 - CNViz: an R/Shiny Application For Interactive Copy Number Variant Visualization in Cancer

Rebecca Greenblatt, Perelman School of Medicine at the University of Pennsylvania

I08 - CloneSeer: Sequence Alignment-Based Detection and Quantification of Lymphoma Sub-Clones

Eitan Halper-Stromberg, Johns Hopkins University

I13 - UNISON: A UNIfied SOmatic CalliNg (UNISON) pipeline for identifying Clonal Hematopoiesis of Indeterminate Potential

Eric Klee, Mayo Clinic

I02 - Human Leukocyte Antigen Typing of Patients with Myeloid Malignancies by Whole Genome Sequencing

Andrew Hughes, Washington University School of Medicine

Platform Presentations of Selected Solid Tumors Abstracts

ST71 - Targeted next-generation sequencing of biliary tract specimens from patients with primary sclerosing cholangitis improves the early detection of cholangiocarcinoma

Aatur Singhi, University of Pittsburgh Medical Center

ST08 - PurIST Pancreatic Cancer Classifier: A 16-RNA Expression Signature Array Comparable to RNAseq

Margaret Gulley, University of NC, Chapel Hill

ST74 - Optical genome mapping for the chromosomal characterization of solid tumors

Ravindra Kolhe, Augusta University

ST57 - Translating Transcriptome Sequencing into Clinical Diagnostics for Pediatric Solid Tumors

Feng Xu, Children's Hospital of Philadelphia

2:30pm - 2:45pm


2:45pm - 4:15pm


Liquid Biopsy and MRD

Use of Patient Specific Panels for MRD Detection

Viktor Adalsteinsson, PhD, Broad Institute of MIT and Harvard, Wakefield, MA, USA

Use of Methylation Signatures for MRD Detection

Dan Landau, MD, PhD, Weill Cornell Medicine, New York, NY, USA

New Applications of CAR T-Cells

CAR T-cell therapies for autoimmune diseases

Michael Milone

“Mechanisms of CAR T cells”

Macela Maus, MD, PhD, Massachusetts General Hospital East, Charlestown, MA, USA

Practical Issues with Quantitative Molecular Testing for Infectious Diseases

Validation of Samples Shared Between Molecular and Other Testing Platforms

Rebecca Harris, University of Pennsylvania and Children's Hospital of Philadelphia, Philadelphia, PA, USA

CMV Viral Load Testing

Randall Hayden, MD, St. Jude Children's Research Hospital, Memphis, TN, USA

Practical Considerations to Optimize Algorithmic Testing for the Diagnosis of HIV

Blake W. Buchan, PhD, Medical College of Wisconsin, Milwaukee, WI, USA

4:15pm - 4:30pm


4:30pm - 5:30pm


Mutational Processes in Cancer Cells and Normal Cells 

Mutational Signature Analysis and its Application to the Clinic

Peter J. Park, PhD, Harvard Medical School, Boston, MA, USA

5:30pm - 5:45pm

Closing Remarks